This, together with the findings that the TME may regulate clonal expansion of cancer-specific T cells44 and that CD8+ T cell proliferative responses are orchestrated by CD103+ Baft3-dependent DCs32 suggest dependence of T cell-mediated tumor regression on the intratumoral presence of CD103+ DCs. The gene discussed is ITGAE; the disease is cancer.